Brief: Bioatla Expects Current Cash And Cash Equivalents To Be Sufficient To Fund Planned Operations Into First Half Of 2024
Nov 15 (Reuters) - Bioatla Inc BCAB.O :
* BIOATLA ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES CLINICAL AND BUSINESS UPDATE
* BIOATLA INC - EXPECT CURRENT CASH AND CASH EQUIVALENTS
WILL BE
SUFFICIENT TO FUND PLANNED OPERATIONS INTO FIRST HALF OF 2024
Source text for Eikon: ID:nPnc9nP1Qa
Further company coverage: BCAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioatla
See all newsBrief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM